Minor concerns underlying contraceptives: Are they valid?

Salem Fahad Alrudian; Tahani Abdulwahab Bitar

doi:10.53730/ijhs.v6nS9.12242

Authors

Salem Fahad Alrudian Assisted consultant obstetric and gynecology, Ministry of health, hail, Saudi Arabia
Tahani Abdulwahab Bitar Nursing Specialist, Ministry of health, Makkah, Saudi Arabia

Keywords:

hormonal contraceptives, Oral contraceptives, Pregnancy

Abstract

The safety of hormonal contraceptives (HCs) has been discussed in multiple studies in the medical literature. HCs are effective contraception methods and are commonly prescribed worldwide. However, Women have many misconceptions leading them to avoid using HCs even when they are indicated. Therefore, the aim of this review was to discuss the most common questions and concerns in an objective manner regarding weight gain, mood changes, libido, the time needed to return to fertility after discontinuation, the effects of simultaneous use of antibiotics and some of the most common side effects. HCs were found to be beneficial in reducing symptoms of many physiological and non-physiological conditions including primary dysmenorrhea, heavy menstrual bleeding, hirsutism, and Endometriosis- related pain. HCs are safe and the available evidence support their usage.

Downloads

Download data is not yet available.

References

A. B. Berenson, S. D. Odom, C. R. Breitkopf, and M. Rahman, “Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills,” American journal of obstetrics and gynecology, vol. 199, no. 4, pp. 351.e1-351.e12, 2008, doi: 10.1016/J.AJOG.2008.04.048.

A. Boozalis, N. T. Tutlam, C. Chrisman Robbins, and J. F. Peipert, “Sexual Desire and Hormonal Contraception.,” Obstetrics and gynecology, vol. 127, no. 3, pp. 563–572, Mar. 2016, doi: 10.1097/AOG.0000000000001286.

A. Dempsey and A. Choi, “Strategies to improve compliance among oral contraceptive pill users: a review of the literature,” Open Access Journal of Contraception, p. 17, Jun. 2014, doi: 10.2147/OAJC.S39111.

A. Fumero, R. J. Marrero, W. Peñate, J. M. Bethencourt, and P. Barreiro, “Adherence to Oral Contraception in Young Women: Beliefs, Locus of Control, and Psychological Reactance,” International journal of environmental research and public health, vol. 18, no. 21, Nov. 2021, doi: 10.3390/IJERPH182111308.

A. Lethaby, M. R. Wise, M. A. Weterings, M. Bofill Rodriguez, and J. Brown, “Combined hormonal contraceptives for heavy menstrual bleeding,” Cochrane Database of Systematic Reviews, vol. 2019, no. 2, Feb. 2019, doi: 10.1002/14651858.CD000154.pub3.

A. M. Nault, J. F. Peipert, Q. Zhao, T. Madden, and G. M. Secura, “Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate,” American Journal of Obstetrics and Gynecology, vol. 208, no. 1, pp. 48.e1-48.e8, Jan. 2013, doi: 10.1016/J.AJOG.2012.10.876.

A. O. Arowojolu, M. F. Gallo, L. M. Lopez, and D. A. Grimes, “Combined oral contraceptive pills for treatment of acne,” The Cochrane database of systematic reviews, no. 7, Jul. 2012, doi: 10.1002/14651858.CD004425.PUB6.

A. Scheuringer, C. Lundin, B. Derntl, B. Pletzer, and I. Sundström Poromaa, “Use of an estradiol-based combined oral contraceptives has no influence on attentional bias or depressive symptoms in healthy women,” Psychoneuroendocrinology, vol. 113, Mar. 2020, doi: 10.1016/J.PSYNEUEN.2019.104544.

B. L. Worly, T. L. Gur, and J. Schaffir, “The relationship between progestin hormonal contraception and depression: a systematic review,” Contraception, vol. 97, no. 6, pp. 478–489, Jun. 2018, doi: 10.1016/J.CONTRACEPTION.2018.01.010.

Burtovaya, N. B. (2020). Teenagers’ maladjustment problem. International Journal of Social Sciences and Humanities, 4(2), 21–29. https://doi.org/10.29332/ijssh.v4n2.402

C. L. Westhoff et al., “Oral contraceptive discontinuation: do side effects matter?,” American journal of obstetrics and gynecology, vol. 196, no. 4, pp. 412.e1-412.e7, 2007, doi: 10.1016/J.AJOG.2006.12.015.

C. L. Wong, C. Farquhar, H. Roberts, and M. Proctor, “Oral contraceptive pill for primary dysmenorrhoea,” The Cochrane database of systematic reviews, vol. 2009, no. 4, 2009, doi: 10.1002/14651858.CD002120.PUB3.

C. Panzer et al., “Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.,” The journal of sexual medicine, vol. 3, no. 1, pp. 104–13, Jan. 2006, doi: 10.1111/j.1743-6109.2005.00198.x.

C. W. Skovlund, L. S. Mørch, L. V. Kessing, and O. Lidegaard, “Association of Hormonal Contraception With Depression,” JAMA psychiatry, vol. 73, no. 11, pp. 1154–1162, Nov. 2016, doi: 10.1001/JAMAPSYCHIATRY.2016.2387.

D. R. Mishell, “Noncontraceptive health benefits of oral steroidal contraceptives,” American journal of obstetrics and gynecology, vol. 142, no. 6 Pt 2, pp. 809–816, 1982, doi: 10.1016/S0002-9378(16)32492-9.

E. J. van Zuuren, Z. Fedorowicz, B. Carter, and N. Pandis, “Interventions for hirsutism (excluding laser and photoepilation therapy alone),” The Cochrane database of systematic reviews, vol. 2015, no. 4, Apr. 2015, doi: 10.1002/14651858.CD010334.PUB2.

G. G. Zhanel, S. Siemens, K. Slayter, and L. Mandell, “Antibiotic and oral contraceptive drug interactions: Is there a need for concern?,” The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, vol. 10, no. 6, pp. 429–33, Nov. 1999, doi: 10.1155/1999/539376.

H. Bengtsdotter et al., “Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use,” The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, vol. 23, no. 1, pp. 45–51, Jan. 2018, doi: 10.1080/13625187.2017.1422239.

H. P. Pagano, L. B. Zapata, E. N. Berry-Bibee, K. Nanda, and K. M. Curtis, “Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review,” Contraception, vol. 94, no. 6, pp. 641–649, Dec. 2016, doi: 10.1016/J.CONTRACEPTION.2016.06.012.

H. S. Jacobs, U. A. Knuth, M. G. R. Hull, and S. Franks, “Post-"pill" amenorrhoea--cause or coincidence?,” British medical journal, vol. 2, no. 6092, pp. 940–942, 1977, doi: 10.1136/BMJ.2.6092.940.

J. K. Aronson and R. E. Ferner, “Analysis of reports of unintended pregnancies associated with the combined use of non-enzyme-inducing antibiotics and hormonal contraceptives,” BMJ evidence-based medicine, vol. 26, no. 3, pp. 112–113, Jun. 2021, doi: 10.1136/BMJEBM-2020-111363.

K. B. Simmons, L. B. Haddad, K. Nanda, and K. M. Curtis, “Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review,” BJOG : an international journal of obstetrics and gynaecology, vol. 125, no. 7, pp. 804–811, Jun. 2018, doi: 10.1111/1471-0528.15027.

K. B. Simmons, L. B. Haddad, K. Nanda, and K. M. Curtis, “Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review,” American journal of obstetrics and gynecology, vol. 218, no. 1, pp. 88-97.e14, Jan. 2018, doi: 10.1016/J.AJOG.2017.07.003.

K. M. Curtis et al., “U.S. Medical Eligibility Criteria for Contraceptive Use, 2016,” MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, vol. 65, no. 3, pp. 1–104, 2016, doi: 10.15585/MMWR.RR6503A1.

K. P. Mark, C. E. Leistner, and J. R. Garcia, “Impact of Contraceptive Type on Sexual Desire of Women and of Men Partnered to Contraceptive Users,” The journal of sexual medicine, vol. 13, no. 9, pp. 1359–1368, Sep. 2016, doi: 10.1016/J.JSXM.2016.06.011.

K. T. Barnhart and C. A. Schreiber, “Return to fertility following discontinuation of oral contraceptives,” Fertility and sterility, vol. 91, no. 3, pp. 659–663, Mar. 2009, doi: 10.1016/J.FERTNSTERT.2009.01.003.

L. F. P. Smith and M. J. Whitfield, “Women’s knowledge of taking oral contraceptive pills correctly and of emergency contraception: Effect of providing information leaflets in general practice,” British Journal of General Practice, vol. 45, no. 397, pp. 409–414, 1995.

L. Iversen, S. Sivasubramaniam, A. J. Lee, S. Fielding, and P. C. Hannaford, “Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners’ Oral Contraception Study,” American journal of obstetrics and gynecology, vol. 216, no. 6, pp. 580.e1-580.e9, Jun. 2017, doi: 10.1016/J.AJOG.2017.02.002.

L. M. Lopez, A. Edelman, M. Chen, C. Otterness, J. Trussell, and F. M. Helmerhorst, “Progestin-only contraceptives: effects on weight,” The Cochrane database of systematic reviews, vol. 7, no. 7, p. CD008815, Jul. 2013, doi: 10.1002/14651858.CD008815.PUB3.

M. F. Gallo, L. M. Lopez, D. A. Grimes, F. Carayon, K. F. Schulz, and F. M. Helmerhorst, “Combination contraceptives: effects on weight,” The Cochrane database of systematic reviews, vol. 2014, no. 1, Jan. 2014, doi: 10.1002/14651858.CD003987.PUB5.

M. J. Rosenberg, M. S. Waugh, and C. M. Stevens, “Smoking and cycle control among oral contraceptive users,” American journal of obstetrics and gynecology, vol. 174, no. 2, pp. 628–632, 1996, doi: 10.1016/S0002-9378(96)70440-4.

M. J. Rosenberg, M. S. Waugh, and T. E. Meehan, “Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation,” Contraception, vol. 51, no. 5, pp. 283–288, 1995, doi: 10.1016/0010-7824(95)00074-K.

P. Barrionuevo et al., “Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 103, no. 4, pp. 1258–1264, Apr. 2018, doi: 10.1210/JC.2017-02052.

P. G. Moorman et al., “Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis,” Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, no. 33, pp. 4188–4198, Nov. 2013, doi: 10.1200/JCO.2013.48.9021.

R. E. Zigler and C. McNicholas, “Unscheduled vaginal bleeding with progestin-only contraceptive use,” American journal of obstetrics and gynecology, vol. 216, no. 5, pp. 443–450, May 2017, doi: 10.1016/J.AJOG.2016.12.008.

R. Sitruk-Ware, A. Nath, and D. R. Mishell, “CONTRACEPTION TECHNOLOGY: PAST, PRESENT AND FUTURE,” Contraception, vol. 87, no. 3, pp. 319–330, 2013, doi: 10.1016/j.contraception.2012.08.002.

Santi, L. K. S., Sudewi, A. A. R., Duarsa, D. P., & Lesmana, C. B. J. (2021). The relationship of pregnancy massage to the rate of anxiety depression and stress in pregnant women. International Journal of Health & Medical Sciences, 4(2), 208-214. https://doi.org/10.31295/ijhms.v4n2.1699

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938

T. Robakis, K. E. Williams, L. Nutkiewicz, and N. L. Rasgon, “Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research,” Current Psychiatry Reports, vol. 21, no. 7, Jul. 2019, doi: 10.1007/S11920-019-1034-Z.

Z. Pastor, K. Holla, and R. Chmel, “The influence of combined oral contraceptives on female sexual desire: a systematic review,” The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, vol. 18, no. 1, pp. 27–43, Feb. 2013, doi: 10.3109/13625187.2012.728643.